U.S. Home Medical Equipment Market Size, Share Analysis Report by 2033
The U.S. home medical equipment market size was exhibited at USD 33.15 Billion in 2023 and is projected to hit around USD 132.94 Billion by 2033, growing at a CAGR of 14.9% during the forecast period 2024 to 2033.
The U.S. home medical equipment (HME) market plays an increasingly essential role in the American healthcare system, reflecting a shift toward decentralized, patient-centric care models. Home medical equipment includes a broad array of devices and support tools used by patients in their residences to manage chronic conditions, recover post-surgery, or receive long-term therapy without requiring prolonged hospitalization. These products improve patient independence, enhance comfort, and reduce healthcare costs by minimizing in-facility care.
The aging population, high prevalence of chronic diseases, rising healthcare expenditure, and technological innovation are collectively driving demand for HME. As baby boomers enter their senior years, the need for home-based care solutions—such as oxygen therapy, mobility assistance, remote monitoring, and dialysis—is expanding rapidly. In addition, the COVID-19 pandemic significantly accelerated the adoption of home-based treatment models, prompting consumers and providers to adopt a more proactive stance toward home healthcare technologies.
Key players in the market offer a wide spectrum of equipment, from therapeutic devices like CPAP machines and home dialysis kits to personal care tools such as grab bars, commodes, and reachers. The growth of digital health has also fueled demand for patient monitoring devices, including wireless blood pressure monitors, heart rate trackers, and glucose sensors, which allow real-time remote diagnostics and data sharing.
Private insurance, Medicare, and Medicaid programs have begun covering more home-use equipment, further bolstering consumer accessibility. Moreover, emerging trends in smart medical devices, AI integration, and connected healthcare ecosystems are transforming the HME landscape, offering new opportunities for innovation and patient empowerment.
Rise in Remote Patient Monitoring: With increasing digitalization, home-use devices integrated with wireless connectivity are enabling real-time remote monitoring by healthcare providers.
Surge in Demand for Oxygen Therapy Devices: Post-COVID complications and respiratory conditions have led to higher demand for home-use oxygen concentrators and CPAP machines.
Growing Popularity of Online Distribution Channels: E-commerce platforms are simplifying access to medical supplies, especially among the elderly and caregivers.
Integration of Smart Technology: AI-enabled features in mobility scooters, blood pressure monitors, and glucose monitors enhance diagnostics and user convenience.
Customization and Ergonomic Design: Companies are focusing on lightweight, compact, and user-friendly designs that are tailored to meet individual comfort and usability needs.
Expansion of At-home Dialysis Solutions: Advances in portable peritoneal and hemodialysis machines are making kidney care more manageable at home.
Policy Reforms Encouraging Home Care: Government initiatives, including the “Hospital at Home” program, are promoting home-based clinical care models.
| Report Attribute | Details |
| Market Size in 2023 | USD 38.09 Billion |
| Market Size by 2033 | USD 132.94 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 14.9% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Distribution Channel, Distribution Channel |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Abbott Laboratories,Baxter International Inc., B. Braun Melsungen AG, Beckton Dickson and Company,General Electric (GE Healthcare), Invacare Corporation, Johnson & Johnson, Medtronic Plc.,ResMed Inc., Smith & Nephew Plc, Medline Industries, LP and SP Ableware |
A major force propelling the U.S. home medical equipment market is the country’s rapidly aging population coupled with a growing chronic disease burden. According to the U.S. Census Bureau, by 2030, all baby boomers will be over 65, accounting for more than 20% of the population. This demographic shift is accompanied by a rise in age-related conditions such as arthritis, diabetes, COPD, and cardiovascular diseases conditions that often require continuous treatment and assistive support.
Home medical equipment, from oxygen delivery systems and mobility aids to remote monitoring devices and beds, enables older adults to maintain quality of life in familiar environments while reducing hospital visits. Medicare’s increasing reimbursement coverage for durable medical equipment (DME) is making such equipment more affordable for elderly populations. Furthermore, a preference among seniors to "age in place" rather than move to long-term care facilities is reinforcing demand for advanced, reliable home medical solutions.
Despite substantial growth prospects, the U.S. home medical equipment market faces challenges rooted in regulatory and reimbursement complexities. The Food and Drug Administration (FDA) mandates stringent approval and classification procedures for many home-use devices, especially those involving electronic or invasive components. Compliance with manufacturing standards, safety certifications, and labeling requirements adds time and cost to the product lifecycle.
In addition, Medicare and Medicaid reimbursement processes are often slow and bureaucratically complex. Variations in state-level policy, limitations on replacement cycles, and documentation requirements pose barriers to market expansion. Suppliers must navigate audits, coding systems (HCPCS), and reimbursement caps, which can dissuade new entrants and create cash flow challenges for distributors. These hurdles can delay access to critical devices and hinder innovation in smaller firms lacking regulatory expertise.
An outstanding opportunity in the U.S. HME market lies in the rapid advancement of smart, connected technologies. From IoT-enabled CPAP machines that transmit sleep data to the cloud, to AI-powered glucometers that offer predictive insights, smart devices are revolutionizing home care. These innovations not only empower patients to manage their conditions more effectively but also enable physicians to track health data remotely and intervene early when issues arise.
The integration of AI, cloud computing, and wearable technology into HME enhances diagnosis accuracy, facilitates personalized therapy, and contributes to preventive healthcare. Devices like Bluetooth-enabled BP monitors, app-linked thermometers, and GPS-tracked mobility scooters represent the future of patient-centric care. Manufacturers investing in telehealth-compatible, easy-to-use, and interoperable solutions are well-positioned to tap into this growing segment. Furthermore, partnerships with digital health companies and EHR platforms are amplifying the reach and effectiveness of such technologies.
Therapeutic equipment dominated the market, primarily due to the high demand for respiratory therapy equipment, home dialysis products, and IV administration kits. The increasing incidence of sleep apnea, chronic obstructive pulmonary disease (COPD), and kidney failure has fueled widespread adoption of home-based therapeutic solutions. CPAP machines and oxygen concentrators are widely used for long-term respiratory management, while home dialysis equipment allows end-stage renal disease (ESRD) patients to maintain a flexible lifestyle without frequent hospital visits. Moreover, home wound therapy products and feeding pumps are enabling post-acute care for patients recovering from surgeries or serious illnesses.
Home dialysis equipment is emerging as one of the fastest-growing therapeutic segments, driven by technological advancements and policy support. Portable peritoneal dialysis machines and home hemodialysis systems are being designed for easier setup, better mobility, and real-time monitoring. Companies like Outset Medical and Baxter International are innovating in this area, empowering patients with user-friendly interfaces, safety alerts, and data analytics. Increased patient autonomy, better quality of life, and lower care costs make home dialysis an attractive alternative to center-based care. Government push for home-first dialysis and favorable insurance coverage are accelerating this trend.
Blood glucose monitors led this segment, given the high prevalence of diabetes in the U.S., where over 37 million people are affected according to CDC data. Patients rely on blood glucose meters to monitor sugar levels and prevent complications like hypoglycemia or hyperglycemia. Advances in continuous glucose monitoring (CGM) devices, such as Dexcom and FreeStyle Libre, offer real-time tracking and mobile alerts, significantly improving patient compliance and control. These devices also integrate with smartphone apps, insulin pumps, and cloud storage platforms, enhancing data access and enabling personalized treatment plans.
Coagulation monitors and apnea monitors are among the fastest-growing, especially for patients on blood thinners and those with sleep disorders or premature infants. As outpatient care becomes common for post-surgery recovery, these devices help clinicians detect abnormalities before they escalate. Apnea monitors, in particular, are in demand among new parents and sleep disorder clinics. They monitor breathing patterns and oxygen levels, triggering alerts for medical intervention. With the expansion of remote patient monitoring programs under Medicare, adoption of these devices is expected to rise rapidly.
Wheelchairs dominated this category, owing to widespread use among seniors, rehabilitation patients, and individuals with physical disabilities. The U.S. market includes manual wheelchairs for temporary or short-distance use, powered wheelchairs for those with severe mobility limitations, and transport chairs for caregiver-assisted mobility. Manufacturers are offering customized wheelchairs with lightweight materials, foldable designs, and smart navigational features for enhanced independence. Veterans and individuals with spinal cord injuries represent significant customer bases supported by government funding and private insurance.
Mobility scooters and walking assist devices are witnessing rapid growth, particularly in urban and retirement communities. These products help users move around homes, stores, and parks safely and comfortably. Lightweight mobility scooters with ergonomic design, long battery life, and terrain adaptability are growing in popularity. Similarly, walkers, rollators, and canes with shock-absorbing features, adjustable height, and anti-slip grips are seeing increased demand. As fall prevention becomes a key priority in senior care, these devices play a critical role in enhancing safety and quality of life.
Offline channels remain dominant, as brick-and-mortar medical supply stores and pharmacies continue to serve as the primary point of sale for many customers, especially seniors. Offline purchases are favored for high-involvement products like mobility equipment, where sizing, fitting, and setup guidance are essential. Additionally, many insurance claims and Medicare reimbursements require purchases through authorized dealers. Hospitals and home healthcare agencies also source large volumes of equipment through offline distributors under negotiated contracts.
Online distribution is the fastest-growing channel, driven by convenience, wider product selection, and competitive pricing. Platforms like Amazon, Walmart, and CVS offer everything from blood pressure monitors and bath safety equipment to CPAP accessories and IV kits. Specialty websites like Apria, 1800wheelchair, and Medline are also expanding direct-to-consumer services. The rise of tech-savvy caregivers and increased digital literacy among seniors is fostering comfort with online purchasing, a trend accelerated by the pandemic. Subscription models, auto-refill programs, and virtual consultations further enhance e-commerce penetration.
In the United States, the home medical equipment market reflects a robust interplay of demographic demand, technological innovation, and evolving care delivery models. States with large senior populations—such as Florida, California, Texas, and Pennsylvania—account for significant demand, especially for mobility aids, monitoring devices, and home therapeutic solutions. Urban centers show high adoption of smart and connected equipment, while rural areas are witnessing growing reliance on telehealth-compatible tools due to limited access to facilities.
Federal initiatives like CMS's Hospital at Home model and expanded Medicare reimbursement for remote monitoring are reinforcing market expansion. Furthermore, private insurance plans are gradually broadening coverage for durable medical equipment (DME), especially for post-discharge care, chronic disease management, and palliative support. Technology hubs such as Massachusetts and California also drive innovation, while logistics and distribution hubs across the Midwest support supply chain efficiencies.
March 2025 – Outset Medical announced a nationwide rollout of its Tablo Hemodialysis System for at-home use, following strong pilot results with Medicare patients.
February 2025 – ResMed released its AirSense 11 CPAP machine with enhanced cloud connectivity and sleep coaching tools, targeting obstructive sleep apnea patients in the U.S.
January 2025 – Invacare Corporation unveiled a new lightweight power wheelchair with smart navigation and caregiver assist tools for use in assisted living settings.
November 2024 – Medline Industries expanded its DTC product catalog, offering bundled home care kits including bath safety products, gloves, thermometers, and wound dressings.
October 2024 – Philips Respironics introduced a new AI-enabled oxygen concentrator integrated with the Care Orchestrator platform for real-time respiratory monitoring.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Home Medical Equipment market.
By Functionality
By Distribution Channel
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers